Effects of adventitial glutaraldehyde cross-linking on biomechanical properties of human saphenous vein graft

doi:10.3969/j.issn.2095-4344.0690

Abstract

Abstract:

BACKGROUND: Poor venous wall is one of the inducing factors causing saphenous vein failure after coronary artery bypass grafting (CABG).

OBJECTIVE: To explore the effects of adventitial glutaraldehyde cross-linking on the biomechanical properties of human saphenous vein graft (SVG).

METHODS: Forty residual segments of SVG were collected from the patients undergoing CABG. Those segments were randomly divided into group A (n=20) and group B (n=20). Adventitial cross-linking was performed with 0.3% glutaraldehyde solution. Each SVG segment in group A was equally subdivided into two parts: one for adventitial cross-linking 5 minutes and the other as self-control. Each SVG segment in group B was also equally subdivided into two parts: one for adventitial cross-linking 10 minutes and the other as self-control. The ultra-structural changes of the venous wall with or without cross-linking were observed by fluorescence microscope and scanning electron microscope. The SVG segments in two groups underwent the uniaxial stretch test to detect the stress-strain relationship, Young’s elastic modulus and breaking strength of SVG segments receiving different processing.

RESULTS AND CONCLUSION: (1) Fluorescence microscope: Compared with the SVGs of self-control, cross-linked SVGs mainly presented with compacted adventitial monomer of collagen and increased density of type I collagen, without obvious ultra-structural changes in the lumen surface. (2) Scanning electron microscope: The adventitial collagen fibers in the self-control segments showed a typical wavy loose arrangement, while the adventitial collagen fibers in the cross-linked segment appeared to have a dense fibrous network. (3) Uniaxial stretch test: Compared with the self-control parts, the stress-stretch ratio curve in the cross-linked parts in the two groups was shifted to the left remarkably, and in the high strain region (stretch ratio 1.3-1.5), the Young’s elastic modulus was also increased significantly (P < 0.05). Compared with the SVGs in the cross-linking 5 minutes, the stress-stretch ratio curve in the SVGs in the cross-linking 10 minutes was shifted to the left remarkably, and in the high strain region (stretch ratio 1.3-1.5), the Young’s elastic modulus was also increased significantly (P < 0.05). The breaking strength of cross-linked SVGs was higher than that of self-control SVGs in the two groups (P < 0.05). To conclude, adventitial glutaraldehyde cross-linking reinforces venous wall and reduces the ductility of human SVG.

中国组织工程研究杂志出版内容重点：生物材料；骨生物材料; 口腔生物材料; 纳米材料; 缓释材料; 材料相容性；组织工程

Key words: Glutaral, Cross-Linking Reagents, Saphenous Vein, Coronary Artery Bypass, Tissue Engineering

CLC Number:

R459.9

R318

Fang Ying, Liu Changcheng, Gu Chengxiong, Yu Yang, Li Zhenfeng, Xu Huanming, Chen Duanduan. Effects of adventitial glutaraldehyde cross-linking on biomechanical properties of human saphenous vein graft[J]. Chinese Journal of Tissue Engineering Research, 2019, 23(2): 226-231.

Figures/Tables 6

References

[1] Goldman S,Zadina K,Moritz T,et al.Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study.J Am Coll Cardiol. 2004; 44(11):2149-2156.

[2] Harskamp RE,Lopes RD,Baisden CE,et al.Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions.Ann Surg. 2013;257(5):824-833.

[3] Gooch KJ,Firstenberg MS,Shrefler BS,et al.Biomechanics and Mechanobiology of Saphenous Vein Grafts. J Biomech Eng. 2018;140(2).doi:10.1115/1.34038705.

[4] Parsonnet V,Lari AA,Shah IH.New Stent for Support of Veins in Arterial Grafts.Arch Surg. 1963;87:696-702.

[5] Taggart DP,Ben Gal Y,Lees B,et al.A Randomized Trial of External Stenting for Saphenous Vein Grafts in Coronary Artery Bypass Grafting.Ann Thorac Surg. 2015;99(6): 2039-2045.

[6] Angelini GD,Lloyd C,Bush R,et al.An external, oversized, porous polyester stent reduces vein graft neointima formation, cholesterol concentration, and vascular cell adhesion molecule 1 expression in cholesterol-fed pigs.J Thorac Cardiovasc Surg. 2002;124(5):950-956.

[7] Goldstone RN,McCormack MC,Khan SI,et al.Photochemical Tissue Passivation Reduces Vein Graft Intimal Hyperplasia in a Swine Model of Arteriovenous Bypass Grafting.J Am Heart Assoc. 2016;5(8). pii: e003856. doi:10.1161/JAHA.116.003856.

[8] Chandran PL,Paik DC,Holmes JW.Structural mechanism for alteration of collagen gel mechanics by glutaraldehyde crosslinking.Connect Tissue Res.2012;53(4):285-297.

[9] Van de Walle AB,Uzarski JS, McFetridge PS.The consequence of biologic graft processing on blood interface biocompatibility and mechanics.Cardiovasc Eng Technol. 2015;6(3):303-313.

[10] Authors/Task Force members,Windecker S,Kolh P,et al.2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).Eur Heart J. 2014;35(37):2541-2619.

[11] Hamedani BA,Navidbakhsh M,Tafti HA.Comparison between mechanical properties of human saphenous vein and umbilical vein.Biomed Eng Online.2012;11:59.

[12] Leask RL,Butany J,Johnston KW,et al.Human saphenous vein coronary artery bypass graft morphology, geometry and hemodynamics.Ann Biomed Eng.2005;33(3):301-309.

[13] Teng ZZ,Ji GY,Chu HJ,et al.Does PGA external stenting reduce compliance mismatch in venous grafts? Biomed Eng Online. 2007;6:12.

[14] Ishiwata S,Tukada T,Nakanishi S,et al.Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis. Am Heart J. 1997;133(4):387-392.

[15] Nguyen HC,Grossi EA,LeBoutillier M,3rd,et al.Mammary artery versus saphenous vein grafts: assessment of basic fibroblast growth factor receptors.Ann Thorac Surg.1994; 58(2):308-310.

[16] Turner NA,Hall KT,Ball SG,et al.Selective gene silencing of either MMP-2 or MMP-9 inhibits invasion of human saphenous vein smooth muscle cells. Atherosclerosis. 2007; 193(1):36-43.

[17] Kim FY,Marhefka G,Ruggiero NJ,et al.Saphenous vein graft disease: review of pathophysiology, prevention, and treatment. Cardiol Rev.2013;21(2):101-109.

[18] Goissis G,Yoshioka SA,Braile DM,et al.The chemical protecting group concept applied in crosslinking of natural tissues with glutaraldehyde acetals.Artif Organs. 1998;22(3): 210-214.

[19] Zilla P,Bezuidenhout D,Weissenstein C,et al.Diamine extension of glutaraldehyde crosslinks mitigates bioprosthetic aortic wall calcification in the sheep model.J Biomed Mater Res. 2001;56(1):56-64.

[20] Kim KM,Herrera GA,Battarbee HD.Role of glutaraldehyde in calcification of porcine aortic valve fibroblasts.Am J Pathol. 1999;154(3):843-852.

[21] Wine Y,Cohen-Hadar N,Freeman A,et al.Elucidation of the mechanism and end products of glutaraldehyde crosslinking reaction by X-ray structure analysis.Biotechnol Bioeng. 2007; 98(3):711-718.

[22] Cheung DT,Perelman N,Ko EC,et al.Mechanism of crosslinking of proteins by glutaraldehyde III. Reaction with collagen in tissues. Connect Tissue Res.1985;13(2):109-115.

[23] Angelini GD,Breckenridge IM,Butchart EG,et al.Metabolic damage to human saphenous vein during preparation for coronary artery bypass grafting.Cardiovasc Res. 1985;19(6): 326-334.

[24] Angelini GD,Soyombo AA,Newby AC.Winner of the ESVS prize 1990.Smooth muscle cell proliferation in response to injury in an organ culture of human saphenous vein.Eur J Vasc Surg. 1991;5(1):5-12.